Skip to main content
. 2022 Feb 15;66(2):e01744-21. doi: 10.1128/AAC.01744-21

TABLE 1.

Clinical and demographic characteristics of patients with BSI episodes presenting with and without septic shockc

Characteristic All episodes (n = 1,563) No septic shock (n = 1,306) Septic shock (n = 257) P value
Demographic data
 Age, median (IQR), yr 59 (48–67) 61 (51–69) 59 (47–66) 0.616
 Male sex 918 (59) 768 (59) 150 (58) 0.896
Underlying disease
 Hematological malignancy 1,348 (86) 1,168 (89) 180 (70) <0.001
 Solid neoplasma 238 (15) 157 (12) 81 (32) <0.001
Hematopoietic stem cell transplant 400 (26) 355 (27) 45 (18) 0.001
 Allogenic/autologous 249/151 (62/38)b 215/140 (61/39)b 34/11 (76/24)b 0.051
Any comorbidity 456 (29) 366 (28) 90 (35) 0.024
Corticosteroid therapy 588 (38) 461 (35) 127 (49) <0.001
Nosocomial BSI (vs health care or community acquired) 999 (64) 883 (68) 116 (45) <0.001
Source of BSI
 Endogenous/unknown 763 (49) 650 (50) 113 (44) 0.089
 Catheter related 333 (21) 309 (24) 24 (9) <0.001
 Abdominal 102 (7) 72 (6) 30 (12) <0.001
 Pulmonary 97 (6) 49 (4) 48 (19) <0.001
 Urinary 83 (5) 62 (5) 21 (8) 0.025
Inappropriate empirical antibiotic therapy 471 (30) 426 (32.6) 45 (17.5) <0.001
 For Gram-positive cocci 290 (18.6) 277 (21.2) 13 (5.1) <0.001
 For Gram-negative bacilli 146 (9.3) 121 (9.3) 25 (9.7) 0.816
Outcome
 Mechanical ventilation requirement 100 (6.6) 29 (2.3) 71 (27.6) <0.001
 30-day mortality 342 (21.9) 201 (15.4) 141 (54.9) <0.001
a

There were 25 patients who had both a hematological malignancy and a solid neoplasm.

b

Percentage among hematopoietic stem cell transplant recipients.

c

Abbreviations: IQR, interquartile range; BSI, bloodstream infection. All values except age are shown as no. (%).